Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TORIPALIMAB Cause Blood creatinine increased? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Blood creatinine increased have been filed in association with TORIPALIMAB (LOQTORZI). This represents 0.9% of all adverse event reports for TORIPALIMAB.

12
Reports of Blood creatinine increased with TORIPALIMAB
0.9%
of all TORIPALIMAB reports
2
Deaths
1
Hospitalizations

How Dangerous Is Blood creatinine increased From TORIPALIMAB?

Of the 12 reports, 2 (16.7%) resulted in death, 1 (8.3%) required hospitalization, and 1 (8.3%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TORIPALIMAB. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does TORIPALIMAB Cause?

Myelosuppression (590) Off label use (276) White blood cell count decreased (144) Anaemia (67) Hypothyroidism (67) Neutrophil count decreased (67) Nausea (60) Rash (59) Vomiting (58) Platelet count decreased (53)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which TORIPALIMAB Alternatives Have Lower Blood creatinine increased Risk?

TORIPALIMAB vs TORSEMIDE TORIPALIMAB vs TOVIAZ TORIPALIMAB vs TOVORAFENIB TORIPALIMAB vs TOZINAMERAN TORIPALIMAB vs TRABECTEDIN

Related Pages

TORIPALIMAB Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased TORIPALIMAB Demographics